Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro - Wikidata - wikimedia - TriplyDB

Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro

Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro

http://www.wikidata.org/entity/Q39851761

about

Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine Interaction between rifabutin and human immunodeficiency virus type 1: inhibition of replication, cytopathic effect, and reverse transcriptase in vitro Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine Neurotoxic effects of AZT on developing and adult neurogenesis Treatment of human immunodeficiency virus infections Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription Possible Biomarkers for the Early Detection of HIV-associated Heart Diseases: A Proteomics and Bioinformatics Prediction Development of dual-acting pyrimidinediones as novel and highly potent topical anti-HIV microbicides Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.Comparative evaluation of virus transmission inhibition by dual-acting pyrimidinedione microbicides using the microbicide transmission and sterilization assay Inhibition of HIV-1 Replication by Secondary Metabolites From Endophytic Fungi of Desert Plants.3'-Azido-3'-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation.A Comparative Systematic Review of the Optimal CD4 Cell Count Threshold for HIV Treatment Initiation.Chromatographic separation of antiviral/anticancer nucleoside reverse transcriptase inhibitor drugs.Therapy of HIV Infection: Current Approaches and Prospects.Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients.A time-of-drug addition approach to target identification of antiviral compounds.Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae.Evidence of alkaline phosphatase interference in a zidovudine radioimmunoassay.Rapid screening method with a cell multisizer for inhibitors of human immunodeficiency virus-induced cell fusion in vitro.Inhibition of human immunodeficiency virus (HIV-1) replication by synthetic oligo-RNA derivatives.Hydroxyurea increases the phosphorylation of 3'-fluorothymidine and 3'-azidothymidine in CEM cells.Inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxynucleoside triphosphates: template dependence, and combination with phosphonoformate.Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.Elimination of both cell-free and cell-associated HIV infectivity in plasma by a filtration/methylene blue photoinactivation system.

P2860

Q24619823-D0980BCD-489E-48A8-9DCC-08DD627E49B9 Q28316430-50ECF242-9E34-4FF1-95AB-9E6BE631F532 Q28338459-A424C448-3911-4A8D-9D96-1235BBBD9770 Q28339082-0A43905A-6F9A-4113-91FF-F4C011705B27 Q28340298-1BDDE8EA-DF46-400D-961A-24BB0DC479F5 Q28342825-9B2E21FF-1FE9-48F7-80E3-C94FEB1F7597 Q28354620-B1B06284-7665-4091-BC38-8BA9F104D033 Q30414740-6334131C-3683-49CB-BC53-09F9C2631E62 Q33740357-1419EA9E-4B16-4C67-9CBD-4960954C2567 Q33854237-7992E7DE-1563-41DB-A367-A7755173EA18 Q35122784-0C819CED-3D92-4FD4-B11C-520309EFC34F Q35143657-7576221C-77DA-4816-9C69-08487DD756ED Q35364134-30EDB30A-FFF6-462D-AC19-E2F08B05BBC2 Q35820362-C75C3537-9975-46FF-ACAD-725356F79B5F Q36353585-E54DA12C-1975-4405-AA8A-F2D9B228C143 Q36441515-DFE9015D-F08D-4C0E-8AC8-90697D1F6F48 Q36803970-378B70FE-C60D-4D24-9ED9-83A384B1CAB2 Q37098542-09E42B94-1973-49A6-83B4-A83EBDE92150 Q37191116-A63798C1-F561-4CB4-9385-70FCBC7D9F41 Q37694057-7DC9F354-64DD-47B1-B974-9C53DB2A9C28 Q37768371-D0AD11E3-7C43-405C-BD00-13AB5AA44F6D Q39066550-CA4EF816-2F8F-4357-8410-A86D809BEEAE Q39179733-29FEB771-237E-4B77-8DD3-2A4CA7CF2162 Q39531429-6E55ADCD-D98D-49D7-8745-75EC4DB9C27E Q39828862-670F0A14-AA6E-4BA0-AE75-E265C9BCC04F Q39867324-93740EE4-0622-464E-8309-E86ED8360B6F Q40194012-00639845-2CFE-49BA-A098-AFD3E817AD87 Q40520429-11E1EDCB-66A0-4BD3-8813-5D3612AD3311 Q41757821-0AF30BE2-3E1E-4DAC-A4EB-45FC008A2A59 Q43915080-4E05E579-E308-4A00-9B13-AF026DDD8C7D Q45846545-B6DEF493-A24F-4177-933D-B86793FA89AA Q50509464-043AB111-A111-484B-973A-DFC53C38BBD6

P2860

Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro

http://www.wikidata.org/entity/Q39851761

description

1986 nî lūn-bûn

@nan

1986年の論文

@ja

1986年学术文章

@wuu

1986年学术文章

@zh-cn

1986年学术文章

@zh-hans

1986年学术文章

@zh-my

1986年学术文章

@zh-sg

1986年學術文章

@yue

1986年學術文章

@zh

1986年學術文章

@zh-hant

name

Inhibition of replication and ...... ido-3'-deoxythymidine in vitro

@en

Inhibition of replication and ...... do-3'-deoxythymidine in vitro.

@nl

type

label

Inhibition of replication and ...... ido-3'-deoxythymidine in vitro

@en

Inhibition of replication and ...... do-3'-deoxythymidine in vitro.

@nl

prefLabel

Inhibition of replication and ...... ido-3'-deoxythymidine in vitro

@en

Inhibition of replication and ...... do-3'-deoxythymidine in vitro.

@nl

P1433

Q39851761-29C755CD-0735-4E03-8C98-03AB0E36B717

P1476

Q39851761-FD423069-17D6-4847-A0A9-EEAB02AA5EBD

P2093

Q39851761-49A0AE98-6517-458B-B4E5-BC64AF0CB9B9

Q39851761-6ACC9F97-537C-44AD-9E32-B9C9F720DF67

Q39851761-727BEAFC-FEDA-4EDA-B0AA-EDFC7DEA03AA

Q39851761-982C2BF0-9B99-413D-AE3A-9C207939577C

Q39851761-C7C4AC63-01F8-481F-A936-C61C4779EC19

Q39851761-E66F1380-EE2F-4397-97EA-31A05F14E802

Q39851761-FB7EDB79-7841-4B76-91C0-AD693E18AAE2

P2860

Q39851761-12D99CED-4E34-4FEB-B817-82D40F02C7FF

Q39851761-21A97B4D-BED3-43D7-BBBC-57B97BEF890A

Q39851761-37551557-6C9C-468A-B07E-60AB1176E988

Q39851761-384438A5-6C1B-4016-B2BE-1BF4AD2D096E

Q39851761-48785219-BF76-4216-9938-6E22746EF7A8

Q39851761-55620E1A-C8AF-4547-BA46-E04FF828F161

Q39851761-6FACC028-0FA0-460A-8EFB-98BA7590FB24

Q39851761-72CB35EC-7E40-4538-A752-3D3A300D3381

Q39851761-827BC785-1411-4DBC-87BD-0B3AFE1C1FAF

Q39851761-83A67B66-6F07-48F2-9DF9-D0950D654516

P304

Q39851761-8B34B383-0903-4339-B982-77675F1B4E0C

P31

Q39851761-6B567448-AC49-4A9D-9A33-78C2A3A889D1

P356

Q39851761-2F37D5EA-C25A-4C0D-B316-BFFE6ED08D68

P407

Q39851761-18AE8D11-6B7D-466A-BED1-A01EABBE6E5A

P433

Q39851761-86A9F6EC-9452-49BB-A437-76EEDF8F9C33

P478

Q39851761-570D8D81-FABD-45FA-977B-CA9081188CDC

P577

Q39851761-BDA8FB61-06CE-4C86-B8E8-D5226563ABB4

P5875

Q39851761-099D3588-F2A9-472E-9918-2F680160FF01

P698

Q39851761-0B6C6BDF-7431-44A7-B732-DEE2D4E81064

P932

Q39851761-138B4FA2-B4F3-4B1E-B971-963A9CE0170B

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Inhibition of replication and ...... ido-3'-deoxythymidine in vitro

@en

P2093

Harada S

http://www.w3.org/2001/XMLSchema#string

Kobayashi N

http://www.w3.org/2001/XMLSchema#string

Matsuda A

http://www.w3.org/2001/XMLSchema#string

Matsui T

http://www.w3.org/2001/XMLSchema#string

Nakashima H

http://www.w3.org/2001/XMLSchema#string

Ueda T

http://www.w3.org/2001/XMLSchema#string

Yamamoto N

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Formation of ribonucleotide 2',3'-cyclic carbonates during conversion of ribonucleoside 5'-phosphates to diphosphates and triphosphates by the phosphorimidazolidate procedure

Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

P304

933-937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.30.6.933

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

1986-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20722134

http://www.w3.org/2001/XMLSchema#string

P698

2434024

http://www.w3.org/2001/XMLSchema#string

P932

180622

http://www.w3.org/2001/XMLSchema#string